Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | SpringerLink
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? | SpringerLink
Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology
Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis | World Journal of Surgical Oncology | Full Text
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications
Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients | BMC Urology | Full Text
Outcome after neoadjuvant chemotherapy in Asian breast cancer patients – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2a5cff93f34ad2baa7b2ce48db639064f71d844d/5-Table3-1.png "PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar")
PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar
Neoadjuvant Chemotherapy and Surgery for Breast Cancer: Preoperative MRI Features Associated with Local Recurrence | Radiology
Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine
Neoadjuvant Chemotherapy and Response | Download Table
PDF) Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence | Scientific Reports
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database | PLOS ONE
Outcome Prediction After Neoadjuvant Chemotherapy (NAC) for Breast Cancer, Using Tumor-infiltrating Lymphocytes Within Fibrotic Foci of Tumor Stroma (FF-TILs) | Anticancer Research
Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - eClinicalMedicine
Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium - European Urology Focus
Neoadjuvant Chemotherapy for Breast Cancer - Unanswered Questions - HealthManagement.org
Frontiers | Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - ScienceDirect
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited | Semantic Scholar
